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The aim of this study was to investigate in human 
skin ill vivo the role of nitric oxide in maintaining 
resting vascular tone, in the vasodilatation caused by 
local warming and by ultraviolet B light exposure, 
and in the response to exogenous calcitonin gene-
related peptide (CGRP). Cutaneous blood flow was 
assessed by planimetry of the visible erythema or 
pallor and by laser Doppler flowmetry. Intradermal 
injection of the inhibitor of nitric oxide synthase, 
NG-nitro-L-arginine methyl ester (L-NAME; 25 
nmol), into forearm skin produced a visible pallor 
and a reduction of blood flow at a controlled ambient 
temperature of 21 °C. The control, N G -nitro-D-argi-
nine methyl ester (D-NAME; 25 n11101) or N G -111on0111-
ethyl-L-arginine (L-NMMA; 25 l1l1101) did not cause 
pallor or reduce blood flow. L-NAME and L-NMMA 
caused dose- and time-dependent increases in pallor, 
and reductions in cutaneous blood flow in skin that 
had been locally war111ed by imm.ersion in water at 
45°C and in skin that had been exposed to ultraviolet 
N itric o xide (NO) is a powerfi.Ii vasodilator synthe-sized by a f.1 111ily of enzym es : the nitric oxide synthases (NOS) [1-3]. NOS has been iml11uno-localized withiJl the endotheliu111 of the large human vasculature [4]. In anim al studies, NOS has 
been immunolocalised in norma l mllJ'ine skin [5], and we have 
recently demonstrated the constituti ve presence of N OS in the 
microvascula ture of normal human digital skin [6] . 
lnhibition of NOS has been shown to alter blood flow in both 
arumal and human tissues [7 ,8]. N G -mo nomethyl-L-arg inine (L-
NMMA) is an inh.ibitor of NOS, and its vasocon strictor action has 
been shown to be endothelium-dep endent, indicating that the 
vasocon striction results from the inhibition of endotheli a.l NO 
generation. It has been postulated, therefore, that tllere is a 
physiological NO-dependent vasodilato r tone that is part of the 
regulation of blood flow and pressure [9] . Nitric oxide released 
fromnonadrenergic and non choEnergic neuro nes m ay also con trib-
ute to the regulation of blood Rowand pressure [10]. Nitl;c ox.ide 
appears to have a role i.n the vasodi.latation of inflammatory 
responses, since inh.ibitors of NOS have been shown to reduce 
oedema in guinea pig skin fo llowing the intradermal inj ection of 
bradykinin , h.istamine, or plate let-activating fac to r [11]. 
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Blight. D-NAME and D-NMMA at comparable con-
centrations did not have the effects on skin blood flow 
observed with the L forms. L-NAME and L-NMMA 
both inhibited the increased blood flow in hU111an 
skin caused by the intradermal injection of CGRP 
(12.5 or 25 p111ol). The reduction of CGRP-induced 
increase of blood flow by L-NAME was reversed b y 
L-arginine. Neither D-NAME nor D-NMMA inhibited 
the increase in blood flow caused by CGRP. Neither 
L-NAME nor L-NMMA inhibited the increase in 
blood flow in human skin caused by the intradermal 
injection of prostaglandin E2 (63 p111ol). The data 
show that nitric oxide is involved in the maintenance 
of resting blood flow in human skin and also in the 
cutaneous vasodilator responses to local warming, 
ultraviolet B irradiation, or injection of CGRP. Key 
IVol,ds: W -nitl'o-L-aJl'gillille metiJyl estel' (L-NAME)IW-
mOllometilyi-L-aJl'gillille (L-NMMA)/UVB lightlca.l~itollilt 
gelle-l'eiated peptide. ] Invest DeJI'matoi 106:113-118, 1996 
Ultraviolet B (UVB)-induced erythem a and sunburn can be 
suppressed by corticos te roids [1 2-1 4] and also by cyclo-o},:ygenase 
inhibitors [15] , but established erythema is not abolished by the use 
of these agents. T herefore, o ther mediators m ay also have a role in 
the produ ction and m aintenance o f UVB-illduced erythema. In 
animal models, it has been shown that the delayed-onset microcir-
culatory vasodilatation induced by endotoxin o r UVB exposure 
involves both NOS and cyclo- oxygenase [16 ,17] . 
N europeptides have b een implica ted in th e control of cu taneous 
blood flow. T hey are involved in axon reflex vasodilatation and 
ha ve been implica ted as m edia tors of neurogenic inflammatio n 
[18 -20]. One n europeptide wim potent v,lsodilato r actions, calci-
tonin gene-related peptide (CGRP), is presen t in neu ro nes ilmer-
vating the microvascul ature of human skin [21]. In tradermal i.nj ec-
tion produces a non-neurogenic erythem a that is slow in o nset and 
long lasting [22]. The mechanism by w hich CGRP induces vaso-
dilatation is unclear, since there is evidence for both endothe lium-
de pendent and endothe lium-independent m echanism s [23,24]. 
T he aim of this study was to determine th e effect of NOS 
inhibitors o n resting cutaneous blood fl ow, on cutan eous blood 
flow fo ll owin g local warming, on UVB irradiation to the skin , an d 
on the in crease in cutaneous blood fl ow caused by CGRP. 
MATERlALS AND METHODS 
Subjects Loca l Ethics COlllmittce approva l for the study was o b tained. 
Adult volunteers of both sexes (age range 18 - 50 years) w ho hud no 
signi ficant past o r current m edical history were lI sl!d fo r the study and gave 
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their infonncd consent. NOlle of the subj ects \vas receiv ing 1l1cdicatioll at 
the time of or ill the 4 wk prior to the stud y. 
Experimental Protocol 
Plallill1('I,-y mul Lasl'r DOI'I'/{'r FlI}//"III'lry ill Norll/al Skill : The aim of thesc 
studies was to determine the role of nitric ox ide in the mainrenance of 
resting c li taneo us vascul ar tonc. All were condu cted in a constant e llviro n-
ment chambcr at 21 °C. Intradermal injections ofa constant volume of25 f.LI 
were placed in randomized sites in the skin of the vo lar surf:1ce of both 
forcarnls. Both investigators and subjects we re unaw;]rc of the con tents of 
the injections at specific sites. For assessment of the size of the area of the 
pallor or erythema, the diameter of the responses was measured in two 
directions at "ight angles , and liom thi s the area of the "esponse was 
calculated. Blood Aow W;IS assessed by laser Doppler Aowmetry (LDF) using 
an infi'ared laser (A = 780 11m) with a power o utpu t at the probe of about 
I mW (Moore Instruments, Oxford, UK) . The factors that determine the 
propagation ofel'ythem3 or pallor, both of which arc assessed by planimetry , 
may be different fron , those that determine the intensity of the response. 
which is as sessed by laser Dopple r Aowmctry. T he output of the laser 
Doppler Aowmeter in arbitrary units is related to average red cel l Aux. and 
was determined at each injection site prior to inj ection (base line) and the" 
at various times after the injection at the same site. 
Loca/ Hl a,.,,,i,,.!:: 111 order to determinc the ro le of nitri c oxide in the 
generation of cutaneous vasodilatation caused by local warming, we 
induced vasodilatation by loca l warming of the skin of the forearm by 
immers ion for 30 s ill water at 45 °C. T he arm was gently and rapid ly dried 
with a towel prior to measurements of the visib le responses and lase r 
Doppler Aowmetc ,' recordings. and pallor measurements were made as 
described above. Laser Doprler ou tput was recorded at the injection sites 
and in addition in the wanned skin adjacent to the injection sites. l3efore 
each set of ll l CaSUrCI11 c nts of the responses to il1tradc [111a l injections, th e artll 
was reimmcrsed in water at 45°C for 30 s. 
UVB Erythellla: Erythema was produced by means of a Kromayer ultravi-
o let ligh t source with a UVB ligh t filter (A = 290-320 nm). A probe was 
attached to the source and appl ied to the volar aspect of the forearms. and 
a I-cm diameter arCa of skin was exposed to the source. The minimal 
erythema dose (MED) was determined in each volunteer. and UVI3-
induced erythema waS eli cited by administration of three times the MED to 
each subject. 
The efFect of L-NAME on evolving and estab li shed UVl3-induced 
erythema was investigated usin g three MEDs of UVl3 at six sites on the 
volar aspect of e;1C h [orcaI'm. C uta neous blood flow was measured by LDF 
prio r to inj"crion over the irrad ia ted areas and at adjacent unexposed sites of 
the forearms. At four forearm sites. L-NAME (25 nnlOl) was administered: 
(i) 10 min prior to UVJ3 irradiation. (ii) at 4 h, (iii) ;It 24 h , and (iv) at 48 h 
after UVJ3. Similarly , four irradiated control sites were injected with saline 
at the same time points. Measurements of blood Aow by laser Doppler 
Aowmetry alld p'll1or size were made at va rious ti mes after the injection of 
L-NAME. 
To determine whether the effects of L-NAME 0 11 UVB-induced ery-
thema were specifi c to NOS ill h ibition. we studied an adelitio/wl fo ur sites 
24 h after UVJ3 irradiation usill g: (i) L-NMMA (25 nmol). (ii) L-NAME (25 
nmol plus the substrate, L-arginine IL-Arg l, 250 nmol), (iii) D-NAME (25 
IImol) , and (iv) till! substrate L-Arg (250 nnlOl ) alo lle . Measurements were 
made at 10 , 20, and 40 lI1in after each injec tion . 
Prosillg/alldill Er illdllred Erylh"IIIII : To ensure that L-NA ME was not acting 
as a vasoconstrictor by II l11 ccilani sl11 unre lated to its acnon o n NOS. the 
eWect of L-NAME on prostaglandin E2 (PGE2)-induced vasod il ;1tation was 
determined at an ambient temperature of2:1 °C . The dose of PGE2 employed 
waS se lected on the basis of pilot studies. Baseline cutaneous blood Aow was 
measur"d prior to injectioll by laser Doppler Aowm elTY. The PGE, and 
l-NAME were co-injected in the same syringe, and measuremel1ts of the 
eryt hema were made hy 10 and 20 min after injection by planimetry and 
laser Doppler Aowmctry. 
N ilric Oxide Sylllh ase Illhibitors alld CC RP'/lIdllat/ Er)'lh"IIIII: To determinc 
if the cuta neous vasodilatation induced by CGRJ> is mediated through the 
synth es is of nitri c o .,;de. two inhibitors or nitri c oxide synthase. L-NAM E 
and L-NMMA. were employed and were each separate ly co-injected with 
CGRP ill Hnl0unts sh ow 11 in the figure legends. MCa SLlfCI11C llts of c rythclllH 
were made by planimetry and laser Doppler Aowmetry. as previously 
described, befo re injection and at 10 ,md 20 min after inj ection. The 
specific ity of the effect of nitri c oxide synthase inhibition was determined by 
the reversal with L-arginine, the substrate for nitric oxide synthase, of the 
eiJcct or I.-NAME. 
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Figure 1. Time courses of changes in cutaneous blood flow at an 
ambient temperature of 21 °C in human skin compared with the 
baseline flow in arbitral'Y units, following il1traderJnal injection of 
L- NAME or L-NMMA ••. L-NAME (25 n11IOI): 0, D-NAME (25 1111101); 
e, L-NMMA (25 I1mol): 0 , D-NMMA (25 I1mol): 6 . saline. Blood Aow is 
represented as change in arbitrary units from baseline of the laser Doppler 
Aow (lDF). Measurements were made at the times shown after the 
injection. Error /1111's. SEM (n = 6). *Significanr difference between L-NAME 
and sa line (p < 0.05). 
Data Analysis T he laser Doppler Ao wmete r output 1'1'0111 a treated arca of 
sk in ilt a given tinlc was expressed as the cha nge in arb itrary units e ither 
fi'om the ou tput at the same site prior to the treatment or fi'om the output 
of sk in ~Idja ccnt to the treated si te (which of these c0l11 pariso ll s \-vas Inadc is 
stated in R.eslI/ts). The areas of pallor or eryt.hema arc given in centil1leter 
squared. Comparisons or l1I eans from sets of data have been mad" using the 
nonparflll1ctric Wilcoxon sig ned r~lnk tcst, si nce the dat:l were not asslImed 
to show a normal distribution . 
Materials L-NAME. D-NAME. I.-arginine. and PGE2 were obtained 
fi'olll Sigma (Poole. UK). L-NMMA and D-NMMA were obtained from 
Ca lbiochelll (Nottingham , UK). CG RY W'IS obtained fro11l Peninsula 
Laboratories (St. I-lelens, Mcrsey,ide, UK). Al l suhstances were prepared a 
a neutral (pH 7) stock at 'lbo ut '1 mM and thell diluted in sterile 
cndotox il1-fi'cc sa line to the required concentratio ll . 
R ESULTS 
The nitric oxide synthase inhibitor L-NAME induces vaso-
constriction in norn~al hun~an skin In human forearm skin, 
intrade rmal injection of th e NOS inhibitOl', L-NAME produced a 
signifi cant a rea of pallor (0 .88 :t 0.20 cm 2 ) 40 min after injection a! 
the controll ed ambi e nt temperature of21 0c. Another NOS inhib-
itor, L-NMMA (25 or 250 nnlOl) did not produce pallor. Neither 
D-NAME, D-NMMA, nor salin e produced visibl e pallor. L-NAME 
but not D-NAME produced a sign ifi cant re ductio n in c utaneous 
blood Aow 40 min afte r inj ectio n (Fig 1). L-NMMA and D-
NMMA f.'1iled to cause a signifi cant redu ctio n in cutaneous blood 
Aow (Fig 1). 
Nitric oxide synthase inhibitors L-NAME and L-NMMA 
induce vasoconstriction in locally warmed skin Table I 
shows that either L-NAME or L-NMMA produced an area ofpa.Uor 
at the site of injection in locally warmed skin 40 min after the 
intradermal inj ection, but there was n o effect after 20 min. In 
contrast, n either at 20 min n o r at 40 min after the inj ection did 
D-NAME or D-NMMA ca u se pallor. The comparable data for 
m easureme nt of c utan eou s blood Aow by lase r Doppler Aowmetry 
is shown in Table II. In these experiments as well, the L-forms of 
NAME and NMMA, but not the D-forms, ca u sed sig nifi cant 
reduction of blood Aow 40 and 20 min after intrade rmal injection. 
F igure 2 shows the dose-response c urves for the a rea of pallor in 
loca ll y wanned skin for both L- NAME and L-NMMA; both 
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Table I. L-NAME Produces Pallor in Warmed Skin 
Area of Pallor (cm 2) 
injection" 
Sa line 
D- NAME (2 5 I1mo l) 
[ -NAME (25 nl1lOl) 
D-NMMA (25 nl11 o l) 
L-NMMA (25 1111101) 
;, Agents were injected illtradc rlnally. 
At 20 min" 
0.12 ::!: 0.08 
0.Q3 ::!: 0.03 
1.04 ::!: 0.20 
0. 13 ::!: 0. 13 
0.30 ::!: 0. 10 
At 4U min 
0.02 ::!: 0 .0 I 
0.04 ::!: 0.04 
1.07 ::!: 0.30" 
0. 10 ::!: 0. 10 
0.54 ::!: 0.01" 
l' lmnlcd iatcly prior to th e mcaS lI.rCIllCIl{"S at 20 and 40 min after il1j ccrio ll . rh t.:: 
forearm was immersed in watc r ;l r 45 °C fo r 30 s to induce c ll taneous vasodi latation. 
The dam arc the men ns ~ SEM fi·(.l 11\ six subjects. 
r Signifi cant d i£fcrcncc compnrcd w ith sa line (p < 0.03). 
compounds produced a dose-related increase in the area of pallor. 
T ime-response re lationships for the area of pallor in loca lly warm ed 
skin for three different concentrations of L-NAME (Fig 3) show 
that the maximum area of pallor produced by L-NAME occurred 
40 min afte r intrade rmal injection . Si milar dose-respo nse cUI'ves 
and time-response rela t ionships were o bserved for L-NAME and 
L-NMMA when the response was assessed by la ser Do ppl er 
flowmetry (data no t shown). 
Nitric oxide syntha'se inhibitors L-NAME and L-NMMA 
inhibit UVB-induced erythema When L-NAME was admin-
istered iml11ediately be fore UVB irradi atio n , there was no signifI-
cant effect on the development and the duration of UVB- induced 
erythe m a. In contrast, however, whe n L-NAME was injected in to 
UVB-exposed sites on the forearm 4, 24, and 48 h after UVB 
irradiation, significant reductions in UVB-induced erythem a were 
recorded by planimetry o r lase r Dopple r How m easurem ents com-
pared with sa line alo nc (Fig 4). The reduction in el'ytherna was 
greatest when L-NAME was administered 24 h after UVll irradia-
tion. In contrast to th e pallo r indu ced by L-N AME in norm al skin. 
the pallor produced by L-NAME injectio n into UYB-irradiated skin 
had a more protracted tim e course and was still present 48 h after 
L-NAME (Fig 5). 
At 24 h after irradia tio n , the reduction in erythem a indu ced by 
L-NAME was partially reversed by the co-administration of the 25 0 
nlnol of the N OS substrate L-A rg (Fig 6) . No significant change in 
visible erythe ma o r blood How was detected after injections of 
O-NAME o r L- Arg alone. A signifi cant reduction orUVB-induced 
erythema was recorded afte r inj ection of a difl:c rent NOS inhib ito r , 
L-NMMA. However, L-NMMA produced a significantly smaller 
red ucti on in erythem a than did L-NAME. 
The nitric oxide synthase inhibitor L-NAME does not in-
hibit PGE2 -induced erythema The dat;1 ill Table III show 
that neith er L-N AME no r D-NAME redu ced the area of erythem a 
or cutaneous blood How induced by in tradcrmal inj ection of 63 
pmol of PGEz. 
Table II. L-NAME Reduces Pallor ill. Warmed Skin 
C ha nge ill LDF" 
Injec tion') At 20 m.in At 40 min 
Saline 5 ::!: 1 4 ::!: 2 
D-NAME (25 IInlO l) 15 ::!: 3 H ::!: 2 
L-NAME (25 111110 1) - 10 ::!: 2" - 11 ::t: ~I r' 
D- NMMA (25 I1mo1) 5 ± 2 2 ± I 
L-NMMA (25 nl11o l) - 7 :': 2' - 10 ::!: l ' 
(/ Agents Wcre illj cc rcd iutradc t"llIaUy. 
/, T he data ;tn.~ the change in laser Do ppler Aowlllctcr (LO F) o utp ut ill arbitr:tq' units 
cOlllp<l rcd with the :tdjaccnr warllled skin ft)l\owi l1g iml1lersion or rhc forcOIrrn for 3D s 
in w:1tcr at 45°C prior [0 c:1 ch set of I\Ic :\SUrCII1L' n rs . T he data arc rhe 1l1ea n s ~ SEM 
fro m six: subjccts. 
( Signifll:am dillc l'c ll cc cOlll pnl'cd w ith saline (p < 0.03 ). 
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Figure 2. Dose-response curves for dte area of tIte pallor induced 
by intradermal injection of L-NAME and L -NMMA in locally 
wa.rlncd hUlnal1 skin. Loca l vvarnli n g \vas achie ved b y inl1l1Crsio n of th e 
fu reann in water at 45 °C for 30 s prior to each set of nl casu rc rnc n ts. 
M casllre lllCntS werc made 40 ll1in aftc r il1j c ri O Il . O. L-NAME; e, L-
NMM A . E,.,..,,. Ion,..\'. SEM (II = 10). 
Nitric oxide synthase inhibitors L-NAME and L-NMMA 
inhibit CGRP-induced erythema F igure 7 shows that the 
erythema indu ced by intradermal injectio n of 25 pmol of CGRP at 
an ambient temperatu re of 21°C was significantl y redu ced by 
co-injection of25 nn101 ofL-NAME but no t by th e co-injection of 
D-NAME; the reduction was apparent at 10 and 20 min aftel' 
inj ection . Table IV shows that L-NMMA (25 o r 250 nmol) but not 
D-NMMA (25 nnlOl) also signifi cantly reduced the size of the 
erythem a induced by twO doses of CGRP, 12.5 and 25 PIllO/. 
Figure 8 illu strates the reversal by 250 11111 0 1 of L- arginine of the 
inhibitory efl:ect of L-NAME on th e increase in cu tan eo LlS blood 
How indu ced by CGRP at both 10 and 20 min afte r injection . 
L-arginine at e ither 25 o r 75 nl11o.\ fa iled to reve rse the actio n of 
L-N AME (data not shown) . 
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Figure 3. Time-response c urves for the area of the p a llor induced 
by the intradermal injection of L-NAME into 10calTy war,"cd 
hUlnan skin. Local wa n11i ll g \vas achieved by inll11crsio n of ehe fo rcann in 
water at 45°C fo r 30 s p ri o r to cach set of m easuremen ts. O . L- NAME (75 
plllo l); e, L-N AM E (2.5 nmo l); • . L-NAME (25 nl1 1OI). E,.r",. bill'S. SEM 
(n = 6). 
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. Figure 4. The effect of L-NAME ou UVB-induced erythema in 
human skin at various times after UVB irradiation. L-NAME (25 
nnlOl; .) or saline ([Sl) as a control was inject.ed into uvn irradiated sites at 
4, 24, and 48 h after the irrad iation. T he response to the injected L-NAME 
was measured 20 min after injection as either (a) the area of visible pallor or 
(iI) the change in laser Doppler Bowll1etry (LDF) in arbitrary uni ts from the 
adj acent nonirradiated ski n. ElTor bars, SEM (n = 6). ' Signifi cant difference 
between L-NAME and sa line (p < 0.(5) . Where no column is shown in 
Pallcl a. nu pa llor was visible. 
DISC USSlON 
Nitric oxide synthase (NOS) has been immunolocalized in murin e 
skin [5] , and nitric ox ide has bee n shown to m ediate vasodilatation 
in ra t skin [8,25] and rabbit skin [26]. III addition , the vasodi lator 
effect of nitric oxide has been shown to contribute to oedema 
fo rmation in g uinea pig skin [11] and rat skin [26]. The constitutive 
e ndothelial isoform of NOS has been immunolocalize d in normal 
human skin microvascul ature [6], and the findings presented in this 
pape r suggest that nitric oxide I'egulates the vascu lar tone of normal 
human skin, ca uses the cutaneous vasodi latation that fo ll ows local 
warming and UVB exposure , and is in vo lved in the vasodilatation 
o bserve d following the injection of exogenous CGRP into normal 
human skin. 
The vasoconstri ction induced b y intradermal injection of L-
NAME in norma l forearm skin impli es that nitric oxide plays a role 
in the mainte nan ce of resting c utaneou s vascu lar to ne . The lack of 
effec t of another NOS inhibitor, L-NMMA, at the same dose as that 
e mploye d for L-NAME is of in teres t. In the subsequent studies 
where both L-NAME and L-NMMA were e mployed, the vasocon-
strictor e ffects of L-NMMA were generall y less pronounced than 
those ofL- NAME. T hi s may be attributabl e to th e lower pote ncy of 
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Figure 5. The duration of action of L-NAME on tbe erythema 
induced in human skin 4 h after UVB irradiation . L-NAME (25 nnlOl ; 
.) or saline ([Sl) as a control was illjeeted into UVB irradiated sites 4 h after 
irradiation. The response to the injected L-NAM E was measured at the 
timcs shown after the iJljection , as either (a) the area of visible pallor or (b) 
the change in laser Doppler flow (LDF), in arb itrary units frol11 the adjacent 
nonirradiated skin. Error bar,., SEM (n = 6). ' Significant difference between 
L-NAME and salinc (p < 0.05). Where no column is shown in Pallcl a, no 
pallor was visib le. 
thi s compound on constitutive NO. W e show in th is paper that 
L-NAME is more potent than L- NMMA in cau sing pallor in 
warmed skin, and th e re is e vide nce from ;/1 1);lro studies on 
endothelial cells that suggests that L-NAME is more potent than 
L-NMMA in inhibiting the constitutive iso fonn of NOS [27] . 
T h e vasocon striction induced b y both L-NAME and L-NMMA 
in skin which had been loca ll y warm ed implies that nitri c ox.ide m ay 
playa role in cutaneous vasodilatation caused b y warming. Fur-
therm ore, the absence of e ffect of either L-NAME o r O-NAM.E on 
vasodilatation indu ced by th e intradermal inj ection of PGEz sug-
gests that L-NAME is not ca using pallor b y a direct vasocon strictor 
action . It has previously been shown that PGEz-induced vasodila-
tation is not atte nuated b y inJlibitors of NOS [28,29]. The m ech-
anism b y which warming indu ces cutaneous vasodilatatio n is not 
completely understood, bu t it is thought to be n e urogeni c , since 
local anaesthe ti c will b lock c utaneous vasodila tation during warm-
ing [30 ,3 1] . In the rabbit, infu sions of the NOS inhibitor, N W-nitro-
L-arginine, in to the lingual artery le d to a reduc tion in ear blood 
flow during warming [32]. 
A study pe rform ed in humans showed no efFec t of brachial artery 
infusions of L-NMMA on forearm blood flow or skin blood flow 
during warming [33 J. T h e protocol of the study by Dietz el at [33) 
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Figure 6. Rcversal by L-argininc (L-Arg) of thc effcct of L-NAME 
on UVB-induccd crythcma in human skill . At 24 h after UVB 
irradiation, the fo llowing injections were made into irradiated sites: . , 
L-NAME (25 nnlOl); mn. L-NAME (25 nmol) + L-Arg; 1m. D-NAME (25 
nnlOl) ; D , L-Arg (250 nmol); 0 , L-N MMA (25 I1mol). At the times shown 
after these injections. responses were measured by planimetry of visible 
pallor. ElTo,. bars. SEM (n = 6). ' Signjficant difi'crence between L-NAME 
and saline (p < 0.05). W here no column is shown. no pallor was visib le. 
differed £i'om that used in the experimen ts reported he re in that 
subjects underwent whole-body heatin g over a period of 50 min , 
whereas we indu ced cutaneous vasodilatation by repeated local 
warming for 30 s. Moreover, Dietz e( tI l [33] in fused L-NMMA into 
the brachia l ar tery, in contrast to the intradermal inj ections th at we 
employed. A lso, L-NAME and L-NMMA may differ in their 
potency or mechanisms of action in large vessels and in the micro-
vasculature, w hich could account for the difference be~veen o ur 
findings and those of D ietz e( tI l [33]. 
We have shown that established UVB-induced erythem a is 
signifi cantly reduced by NOS inhibition . Corticosteroids and cy-
clooxygenase inhibi tors are known to modify UVB-induced e ry-
thema [19,34-37]. Prostaglandins, it has been postulated, could be 
involved in the early injury response to VVB exposure. Cortico-
steroids may act in the subseq uent 24 h by inhibition of leukocyte 
migration, cytokine production, NO productio n , and phospho-
lipase A 2 activity. W hether NOS inhibitors are actin g on the 
constitutive and/or inducible iso form of NOS in the atten uation of 
the VVB erythema is unknown. T he prolonged time course of the 
L-NAME-induced pallo r in the VVB erytllema compared with the 
pallor in norm al skin (24 liS 2 h) ma y indi cate that whi le L- NAME 
inhibits the constitutive isoform of NOS in normal human skin, the 
inducible isoform of NOS is functiona l in VVB irradiated skin. 
Increased epidermal synthesis of the cytokine interl eukin-l has 
been demonstrated fo llowing UVB irradiation [38], and in terleu-
Table III. L-NAME Fails to Inhibit PGE2 -Induced 
Erythelua" 
Injection 
PGE2 
PGE, + L-NAME 
PGE2 + D-N AME 
Area of Erythema (cm2 ) 
At 10 min 
1.3 ~ 0.4 
0.9 ~ 0.1 
1.2 ~ 0.4 
At 20 min 
1.0 ~ 0.1 
0.9 ~ 0.1 
1.3 ~ 0.3 
Change in LDF 
(a rbitrary uni ts) 
At 10 min 
24 ~ 4 
25 ~ 5 
23 ~ 6 
At 20 min 
23 ~ 3 
19 ~ 4 
29 ~ 4 
" The e ffect of L-NAME and its D form a ll the size ofcryth cm :1 and change in blood 
How induced in human skin ;It :111 ambient temperature of 2 1 DC by the inj ection of 
PGE,. T he amoun ts of substanccs injected wcre PGE,. 63 p111o l; L-NAME. 25 nn !Ol: 
and D-NAME, 25 Ilmo l. T he change in laser Doppler flowmeter (LDF) outpu t ill 
arbitrary units was calcui;1(cd from the values obta ined <It the inj ection site before Hllrl 
afte r injection , fit the t imes given . T he data 'Ire the means ± SEM from six subjects . 
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Figure 7. T he effcct of L-NAME on thc area of CGRP-illduced 
crythema in hunlan skill at an alllbicllt temperature of 21°C. 
L-NAME and CGRP were co-injected intraderma ll y. D, CGR.P (25 pl11ol); 
., CG RP (25 pl11ol) + L-NAME (25 I1Inol); D, CGRP (25 1'mol) + 
D-NAME (25 nmol) . Measurements were made 10 and 20 mjll after the 
injection. E/1'''/' bars. SEM (n = 10) . ' Significant difFerence between CGIU) 
alone and CGRP + L-NAME (1' < 0.05). 
kin-l is a potent stimulus for inducible NOS [39]. Other inflam-
matory mediators m ay aJso generate indu cible NOS, since tlus 
involves the activation of protein kinase C and of the transcrip tion 
factor, nuclear factor kappa B (NFKB) [40-42] . 
CGRP is a putative m ediator of ne uron aUy m ediated vasodi lata-
tion that is released fi'ol11 perivascular nerves [43]. When inj ected 
intradermally. exogenous CGRP causes a non-neurogenic ery-
them a [22], and the data presented here show that the CGRP-
induced vasodilatation is inhibi ted by both L- NAME and L-
NMMA . Moreover, the effect ofL- NAME was reversed by L- Arg, 
indicating its specificity as an inhibitor of NOS. It would appear , 
therefore, that NO m ediates, at least .in part, the vasodi latation 
induced by CGRP in the nucrovasculature of human skin ;/1 V; /IO. 
T he role of NO in CGRP-med iated vasodi latati on seem s to vary 
depending on species and /or the veSsels in volved. Marshall [23] has 
shown that in the aorta and in the resistan ce vessels of the rat 
m esentery, CGRP-induced vasodilatatio n is endothelium depen-
dent, but in rat skin NOS inhibitors were fou nd not to attenuate 
CGRP-induced vasodilatation. Tn rat skin , L-NM.MA and N G _ 
nitro-L-arginine did not inhibit CGRP- induced vasodilatation [24]. 
1n rabbit skin, L-NAME was fo und not to have 3n inhibitory e ffect 
o n CGRP-induced vasodilatation [44]. In the same study in rabbit 
skin , L-NAME was, however , found to inhibi t capsaicin-induced 
vasodilatation. T he hum an aCGIUJ antagonist, CGRP~_37 ' was 
also fo und to inlubit capsaicin-induced vasodilatation , implying that 
in rabbit skin ne urogenic vasodilatation m ay act via sepa rate NO-
and CGRP-dependent m echanisms. 
Table IV. L-NMMA Inhibits CGRP-Induced Erythema" 
Area of Erythema (cm1 ) 
AmoLlnt of Amoul1t of L- Or 
CGRP (p rnol) D-NMMA (nnlOl) At 10 min At 20 min 
12.5 0 0.89 ~ 0. 19 0.89 ~ 0.14 
25 0 0.87 ~ 0.08 I .09 ~ 0.09 
12.5 25 (L) 0.38 ~ 0. 13" 0.48 ~ 0.13" 
12.5 250 (L) 0.04 ~ 0.04" 0.16 ~ 0.10" 
25 25 (L) 0.54 ~ 0.06' 0.79 ~ 0.09" 
25 25 (D) 0.87 ~ 0.10 0.99 ~ 0.10 
,I L-NMMA or its D form were co-injected il1tnld cfmally with CG l"lP. and the size 
oCthe erythema indu ced in nOfmalltul11an skin at an :1muicllr temperature of21 °C was 
measured. T he dara arc the Il1C :l n s :t SEM from e ight subjec t!". 
/" '" Signifi l::lnt differences between CG I~P alone and CG RP plus L-Nrv\MA (" p < 
0.02 and ' p 0.05). 
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Figure 8. The reversal by L-arginine of the L-NAME-induced 
inhibition of the increase in blo()d flow caused by CGRP in human 
skin at an ambient temperature of 21°C . L-arginine, L-NAME. and 
CC Rl) were co-injcc tcd intradc rrnally . Th" change fi:om basel inc in blood 
fl o w l11 ea.<ured by 1 :I ~er Do ppler fl o wmctry (LDP) is shown in arbitrary 
ulli ts. Measurements we re made at 10 and 20 min after the injec ti o n o f the 
substanccs . D , CC RY (25 pl1lo l) ; • . CG RP (25 plllol) + L-NAME (25 
111110 1); O. ecru) (25 />111 01) + L-NA ME (2 5 1111"1 0 1) + L-arginine (250 
IIInol) . Error/ln rs, SEM (11 = '10). ' Signifi cant difference between CCIl..P + 
L- NAME and CG R.P + L-NAME + L-arginine (p < 0.05). 
P.C. Co/dsllli/It is a )If/ ell, ,,,"c 1'1"115/ Cli"ical R.cscnr, (' Fell"",. Hie tl{(I1'" tl,c 
",,!tll/(ccrs llJ/W .f!l'II CI'OIlS /)' gn lJc lheir lillie 10 participate ill these stlldies . 
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